Caxton Associates (New York)’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $536K | Buy |
+10,632
| New | +$536K | 0.02% | 316 |
|
|
2020
Q3 | – | Sell |
-53,222
| Closed | -$895K | – | 335 |
|
|
2020
Q2 | $895K | Buy |
53,222
+30,102
| +130% | +$506K | 0.08% | 60 |
|
|
2020
Q1 | $275K | Buy |
23,120
+1,447
| +7% | +$17.2K | 0.05% | 272 |
|
|
2019
Q4 | $262K | Buy |
+21,673
| New | +$262K | 0.04% | 296 |
|
|
2017
Q4 | – | Sell |
-10,300
| Closed | -$199K | – | 318 |
|
|
2017
Q3 | $199K | Buy |
+10,300
| New | +$199K | 0.01% | 425 |
|